IBA signs $30 million contract with the University of Florida Health Proton Therapy Institute

IBA (Ion Beam Applications S.A.), which develops proton therapy technology for the treatment of cancer, announced it has signed a contract with the University of Florida Health Proton Therapy Institute (UFHPTI) to install a new ProteusOne system and to upgrade its current proton therapy equipment with IBA’s latest technologies.

IBA will equip UFHPTI with its compact ProteusOne system, which includes its next-generation precision technologies of Pencil Beam Scanning (PBS) and Cone Beam CT (CBCT) capabilities as well as the Philips Ambient Experience. UFHPTI has treated more than 6,000 patients with IBA technology since 2006. In addition to the ProteusOne, existing proton therapy systems will be upgraded with the latest in IBA technologies, including PBS, CBCT as well as adaPT Insight, IBA’s platform for adaptive proton therapy and patient-centric workflow.

In total, the contract is worth approximately $30 million to IBA. The UFHPTI expansion and addition of the ProteusOne system is estimated for completion in 2018. The installation of new PBS and CBCT technologies in the existing proton therapy system will start once the new ProteusOne system is installed. The contract also includes an operation and maintenance agreement for the ProteusOne system.